Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Bruce David Cheson
Lymphoma Consultant
Block
Formerly at NCI and Head of Hematology at Georgetown University Hospital, 5 decades developing new drugs for CLL and lymphoma and establishing response criteria.
29
Talks
336.7k
Listens
Talks
Clonal Hematopoiesis in CLL
March 26, 2026
Share
Clonal Hematopoiesis in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10969
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Nivo-AVD in Hodgkin
March 26, 2026
Share
Nivo-AVD in Hodgkin
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10971
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Venetoclax Retreatment
March 19, 2026
Share
Venetoclax Retreatment
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10954
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Patient BTKi Preferences
March 19, 2026
Share
Patient BTKi Preferences
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10957
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Mosunetuzumab in Richter’s
March 19, 2026
Share
Mosunetuzumab in Richter’s
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10955
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Zanubrutinib in 17p-CLL
March 9, 2026
Share
Zanubrutinib in 17p-CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10795
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Hypertension in CLL
March 9, 2026
Share
Hypertension in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10793
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
BTKi Discontinuation Rates in CLL
March 9, 2026
Share
BTKi Discontinuation Rates in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10791
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Withdrawal of Tazemetostat
March 9, 2026
Share
Withdrawal of Tazemetostat
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10790
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
CART for CNS Lymphoma
February 23, 2026
Share
CART for CNS Lymphoma
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10723
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Acalabrutinib in Older and/or Frail Patients with CLL
February 6, 2026
Share
Acalabrutinib in Older and/or Frail Patients with CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10371
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
CNS Involvement in CLL
February 2, 2026
Share
CNS Involvement in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10347
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Zanu + Ven in Poor Risk CLL
February 2, 2026
Share
Zanu + Ven in Poor Risk CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10342
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
LOTIS-7 Study in DLBCL
February 2, 2026
Share
LOTIS-7 Study in DLBCL
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10348
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Zanu/Sonrotoclax in CLL
February 2, 2026
Share
Zanu/Sonrotoclax in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10345
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
ROSEWOOD Study Analysis
February 2, 2026
Share
ROSEWOOD Study Analysis
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10346
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
inMIND Trial
February 2, 2026
Share
inMIND Trial
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10349
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Epcoritamab in CLL
February 2, 2026
Share
Epcoritamab in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10343
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
AMPLIFY Phase III Trial
February 2, 2026
Share
AMPLIFY Phase III Trial
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10340
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Epcoritamab in elderly LBCL
January 19, 2026
Share
Epcoritamab in elderly LBCL
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10263
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Lisaftoclax in CLL
January 19, 2026
Share
Lisaftoclax in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10262
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Rocbrutinib
January 19, 2026
Share
Rocbrutinib
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10261
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
R-glofit-pola in elderly LBCl
January 19, 2026
Share
R-glofit-pola in elderly LBCl
https://www.medspoke.co/channel_playlist?object_id=683&tap_id=10260
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Resistance to Pirtobrutinib
January 17, 2026
Share
Resistance to Pirtobrutinib
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10259
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
BGB-16673 in CLL
January 17, 2026
Share
BGB-16673 in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10258
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Limited duration acalabrutinib
January 17, 2026
Share
Limited duration acalabrutinib
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10257
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Pirtobrutinib vs BR in CLL
January 17, 2026
Share
Pirtobrutinib vs BR in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10256
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Bexobrutideg in CLL
January 17, 2026
Share
Bexobrutideg in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10254
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Pirtobrutinib vs Ibrutinib in CLL
January 16, 2026
Share
Pirtobrutinib vs Ibrutinib in CLL
https://www.medspoke.co/channel_playlist?object_id=794&tap_id=10253
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Why are you reporting this TALK?
